Literature DB >> 9182908

Adhesion molecules: a rheumatologic perspective.

C F Mojcik1, E M Shevach.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9182908     DOI： 10.1002/art.1780400602

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  34 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages.

Authors:  C-Y Chen; C-H Tsao; L-S Ou; M-H Yang; M-L Kuo; J-L Huang
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

Review 3.  New therapies in development for autoimmune diseases: their rationale for combination treatment.

Authors:  V Strand
Journal:  Springer Semin Immunopathol       Date:  2001

4.  Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.

Authors:  R A Carter; I K Campbell; K L O'Donnel; I P Wicks
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.

Authors:  Jining Liu; Jinfa Ying; Vincent T K Chow; Victor J Hruby; Seetharama D Satyanarayanajois
Journal:  J Med Chem       Date:  2005-10-06       Impact factor: 7.446

6.  Serum-soluble selectin levels in patients with Behçet's disease.

Authors:  Aşkin Ateş; Olcay Aydintuğ Tiryaki; Umit Olmez; Hüseyin Tutkak
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

7.  Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts.

Authors:  Y Hosokawa; I Hosokawa; K Ozaki; H Nakae; T Matsuo
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

8.  Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.

Authors:  P A Klimiuk; S Sierakowski; R Latosiewicz; J P Cylwik; B Cylwik; J Skowronski; J Chwiecko
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

9.  Activated T-lymphocytes express occludin, a component of tight junctions.

Authors:  J S Alexander; T Dayton; C Davis; S Hill; T H Jackson; O Blaschuk; M Symonds; N Okayama; C G Kevil; F S Laroux; S M Berney; D Kimpel
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

10.  A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.

Authors:  D Elewaut; F De Keyser; N De Wever; D Baeten; N Van Damme; G Verbruggen; C Cuvelier; E M Veys
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.